Columbia Financial CEO granted stock units
Columbia Financial’s CEO received a small stock-based deferral award while maintaining large direct share and option positions in CLBK.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Columbia Financial, Inc. (CLBK) reports that President & CEO Thomas J. Kemly received an award of about 159 shares of Common Stock on September 4, 2026 at $11.70 per share, credited as phantom stock under the Columbia Bank Stock Based Deferral Plan and held indirectly through a rabbi trust. Following this award, he indirectly holds about 154,636 share-equivalent units in that plan, plus substantial direct and indirect Common Stock holdings and multiple stock option grants with exercise prices between $7.10 and $8.31 per share. No Rule 10b5-1 trading plan is reported and no open-market purchases or sales are shown.
Insider Trade Summary
Grant/Award: 158.7769 shares
Grant/Award
1 txn
Insider
Kemly Thomas J.
Role
President & CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 158.7769 | $11.70 | $2K |
| Holding | Stock Options (right to buy) F5 | -- | -- | -- |
| Holding | Stock Options (right to buy) F5 | -- | -- | -- |
| Holding | Stock Options (right to buy) F6 | -- | -- | -- |
| Holding | Stock Options (right to buy) F7 | -- | -- | -- |
| Holding | Stock Options (right to buy) F8 | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock F2 | -- | -- | -- |
| Holding | Common Stock F3 | -- | -- | -- |
| Holding | Common Stock F4 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 154,636.364 shares (Indirect, By Stock-Based Deferral Plan);
Stock Options (right to buy) — 2,019,067 contracts (Direct);
Common Stock — 588,391 shares (Direct);
Common Stock — 103,581 shares (Indirect, By 401(k));
Common Stock — 91,850 shares (Indirect, By SIM);
Common Stock — 19,198 shares (Indirect, By ESOP);
Common Stock — 78,014 shares (Indirect, By SERP);
Common Stock — 13,052 shares (Indirect, By Spouse);
Common Stock — 101,371 shares (Indirect, By Stock Award III);
Common Stock — 120,318 shares (Indirect, By Stock Award IV);
Common Stock — 118,452 shares (Indirect, By Stock Award V)
Holdings Before and After:
Common Stock, 154,477.5871 to 154,636.364 shares (Indirect, By Stock-Based Deferral Plan)
Footnotes (8)
- F1. Represents phantom stock purchased, on a non-discretionary basis, by the trustee of the Bank's rabbi trust maintained in connection with the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan. Stock unit interests under the Columbia Bank Stock Based Deferral Plan will be settled in shares of stock upon distribution to the reporting person.
- F2. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, 25% of which vest in three approximately equal annual installments commencing on March 6, 2025; and the remaining 75% of which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award.
- F3. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award on March 3, 2028.
- F4. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award on March 2, 2029.
- F5. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan are fully vested and exercisable.
- F6. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 6, 2025.
- F7. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 3, 2026.
- F8. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 2, 2027.
Key Figures
Awarded Common Stock (phantom units): 159 shares at $11.70 per share
Deferral Plan Holdings: 154,636 share-equivalent units
Direct Common Stock Holdings: 588,391 shares
+5 more
8 metrics
Awarded Common Stock (phantom units)
159 shares at $11.70 per share
Grant/award acquisition on September 4, 2026 under the stock-based deferral plan
Deferral Plan Holdings
154,636 share-equivalent units
Indirectly held by Stock-Based Deferral Plan after the September 4, 2026 award
Direct Common Stock Holdings
588,391 shares
Common Stock held directly by the CEO as of September 4, 2026
401(k) Plan Holdings
103,581 shares
Common Stock held indirectly by 401(k)
Largest Option Grant
1,444,236 underlying shares at $7.10
Stock Options (right to buy) fully vested and exercisable, expiring July 23, 2029
Additional Option Grant
208,447 underlying shares at $7.38
Stock Options (right to buy) expiring March 3, 2035
Spouse Holdings
13,052 shares
Common Stock held indirectly by spouse
Stock Award III Holdings
101,371 shares
Indirect holdings by Stock Award III, subject to vesting/performance criteria
Key Terms
phantom stock, rabbi trust, non-qualified stock-based deferral plan, Stock Options (right to buy, +1 more
5 terms
phantom stock financial
"Represents phantom stock purchased, on a non-discretionary basis, by the trustee"
A phantom stock is a form of compensation that gives employees or executives the benefits of stock ownership, such as the increase in stock value, without actually giving them real shares. It acts like a promise to pay the employee the equivalent value of company stock later, often as a bonus or incentive. This allows companies to motivate and reward staff without diluting ownership or transferring actual shares.
rabbi trust financial
"by the trustee of the Bank's rabbi trust maintained in connection with"
A rabbi trust is a special account a company sets up to hold promised future pay for executives, like bonus or retirement money, so those employees can see there are funds earmarked for them. It matters to investors because it signals the company’s commitment to keep key people, but the money is still part of the company’s assets and can be claimed by creditors if the company goes bankrupt—think of it as a labeled jar that isn’t completely off-limits.
non-qualified stock-based deferral plan financial
"Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan"
Stock Options (right to buy financial
"Stock Options (right to buy) granted pursuant to the Columbia Financial, Inc."
performance-based vesting criteria financial
"vest upon achievement of certain specified performance-based vesting criteria"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did CLBK’s CEO acquire in the latest Form 4 filing?
The CEO acquired an award of about 159 shares of Columbia Financial Common Stock on September 4, 2026 at $11.70 per share, recorded as phantom stock in the Columbia Bank Stock Based Deferral Plan and to be settled in shares upon distribution.
What indirect CLBK holdings does the CEO have through benefit plans?
Indirectly, the CEO holds approximately 154,636 share-equivalent units in the stock-based deferral plan, plus 103,581 shares via a 401(k), 19,198 via an ESOP, and 78,014 via a SERP, as reported in the Form 4.
Were the CLBK CEO’s transactions under a Rule 10b5-1 trading plan?
No. The filing indicates no Rule 10b5-1 trading plan, and it reports a compensatory stock-based deferral award and updated holdings rather than open-market purchases or sales.
AI-generated analysis. How Rhea-AI works. Not financial advice.
